Literature DB >> 24592500

Does the net reclassification improvement help us evaluate models and markers?

Andrew J Vickers, Margaret Pepe.   

Abstract

Mesh：

Year:  2014        PMID： 24592500     DOI： 10.7326/M13-2841

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  18 in total

1.  Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.

Authors:  Peggy M Cawthon; Terri L Blackwell; Jane Cauley; Deborah M Kado; Elizabeth Barrett-Connor; Christine G Lee; Andrew R Hoffman; Michael Nevitt; Marcia L Stefanick; Nancy E Lane; Kristine E Ensrud; Steven R Cummings; Eric S Orwoll
Journal:  J Am Geriatr Soc       Date:  2015-10-27       Impact factor: 5.562

2.  Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Authors:  Laine E Thomas; Emily C O'Brien; Jonathan P Piccini; Ralph B D'Agostino; Michael J Pencina
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

3.  Response.

Authors:  Margaret Sullivan Pepe
Journal:  J Natl Cancer Inst       Date:  2014-11-27       Impact factor: 13.506

4.  How good are we at predicting the fate of someone with acute myeloid leukaemia?

Authors:  E Estey; R P Gale
Journal:  Leukemia       Date:  2017-03-17       Impact factor: 11.528

Review 5.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 6.  Key concepts and limitations of statistical methods for evaluating biomarkers of kidney disease.

Authors:  Chirag R Parikh; Heather Thiessen-Philbrook
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

7.  Towards better clinical prediction models: seven steps for development and an ABCD for validation.

Authors:  Ewout W Steyerberg; Yvonne Vergouwe
Journal:  Eur Heart J       Date:  2014-06-04       Impact factor: 29.983

8.  First things first: risk model performance metrics should reflect the clinical application.

Authors:  Kathleen F Kerr; Holly Janes
Journal:  Stat Med       Date:  2017-12-10       Impact factor: 2.373

9.  25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension--Is it worth the "hype"?

Authors:  Erin D Michos; Pamela L Lutsey
Journal:  Atherosclerosis       Date:  2015-12-15       Impact factor: 5.162

10.  Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.

Authors:  So Hee Song; Joong Hyun Ahn; Ho Yun Lee; Geewon Lee; Joon Young Choi; Jun Kang; Eun Young Kim; Joungho Han; O Jung Kwon; Kyung Soo Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Young Mog Shim
Journal:  Eur Radiol       Date:  2015-10-11       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.